Upregulation of HAb18G/CD147 in activated human umbilical vein endothelial cells enhances the angiogenesis

Previous studies demonstrated that CD147 molecule, highly expressed on the surface of various malignant tumor cells, significantly correlated with the malignancy of these cancers; however, the role of HAb18G/CD147 in endothelial cells has yet to be established. In this study, we found that the expre...

Full description

Saved in:
Bibliographic Details
Published inCancer Letters Vol. 278; no. 1; pp. 113 - 121
Main Authors Chen, Yanke, Zhang, Hongxin, Gou, Xingchun, Horikawa, Yohei, Xing, Jinliang, Chen, Zhinan
Format Journal Article
LanguageEnglish
Published Ireland Elsevier Ireland Ltd 08.06.2009
Elsevier BV
Elsevier Limited
Subjects
Online AccessGet full text
ISSN0304-3835
1872-7980
1872-7980
DOI10.1016/j.canlet.2009.01.004

Cover

More Information
Summary:Previous studies demonstrated that CD147 molecule, highly expressed on the surface of various malignant tumor cells, significantly correlated with the malignancy of these cancers; however, the role of HAb18G/CD147 in endothelial cells has yet to be established. In this study, we found that the expression of HAb18G/CD147 was significantly upregulated in activated HUVECs. The inhibition of HAb18G/CD147 expression by specific siRNA led to significantly decreased angiogenesis in vitro. Our data indicate that HAb18G/CD147 may regulate angiogenesis via several mechanisms including proliferation, survival, migration, MMPs secretion, and PI3K/Akt activation. Our findings for the first time suggest that upregulation of HAb18G/CD147 in activated HUVECs might play an important role in angiogenesis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0304-3835
1872-7980
1872-7980
DOI:10.1016/j.canlet.2009.01.004